Tumour angiogenesis has long been a focus of anti-cancer therapy; however. anti-angiogenic cancer treatment strategies have had limited clinical success. Tumour-associated myeloid cells are believed to play a role in the resistance of cancer towards anti-angiogenesis therapy. but the mechanisms by which they do this are unclear. https://parisnaturalfoodes.shop/product-category/wintergreen-oil/